Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 replaces the older Revision: v3.4.0 on the page, indicating a version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedUI updates add a 'Show glossary' option and update QC-related fields (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with the revision updated to v3.4.0 (from v3.3.4).SummaryDifference0.1%

- Check42 days agoChange DetectedA minor revision banner update was made: Revision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study locations were expanded to include many new sites across the US, Canada, and other regions, and the HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check91 days agoChange DetectedA new sentence is added to Publications indicating publications are provided voluntarily by the submitter, and the descriptor changes from 'about the study results' to 'about the results of the study'; the revision tag updates to v3.3.2 (replacing v3.2.0).SummaryDifference0.3%

- Check99 days agoChange DetectedThe page's notice about government funding status was removed; no study content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.